Owing to their capacity to induce strong, sequence-specific, gene silencing in cells, short interfering RNAs (siRNAs) represent new potential therapeutic tools. This development requires, however, new safe and efficient in vivo siRNA delivery methods. In the present technical report, we show that electrically mediated siRNA transfer can suppress transgene expression in adult mice muscles. Using electropulsation for siRNA delivery opens the way for a targeted gene silencing on a broad range of tissues. Clinical applications of electropulsation for delivery of other classes of molecules are under trials. We reported that gene silencing was efficiently obtained in vivo in an adult mammal (mouse) with chemically synthesized siRNA after its electrical delivery. The associated gene silencing was followed on the same animal and lasted at least 11 days. Gene silencing was obtained in muscles not only on young adult mice but also on much older animals. No tissue damages were detected under our electrical conditions. Therefore, this method should provide an efficient approach for a localized delivery of siRNAs in various tissues and organs. Gene Therapy (2005) 12, 246-251.
Introduction
Since its discovery, 1 RNA interference has been described and extensively characterized in a number of organisms. [2] [3] [4] The identification of the short interfering RNAs (siRNAs) involved in this process and their use for sequence-specific gene silencing have offered a new approach for molecular therapeutics by taking advantages of the progress in genomics. 5, 6 This development requires, however, new safe and efficient in vivo siRNA delivery methods. 7 siRNAs appear as a very promising new therapeutical agent but besides the problem of delivery, an unanswered problem is to know how long its effect lasts after a single dose delivery. 8 Most recently published in vivo results were obtained by 'hydrodynamic transfection'. This stringent approach (injection within a few seconds in the tail vein of a volume onetenth the mass of the animal) appears to bring siRNA (and DNA) delivery mainly targeted to the liver. [9] [10] [11] [12] [13] Other methods were described where a systemic or a localized (portal vein injection) delivery was obtained by adding different chemical compounds to the siRNA solution.
14-17 siRNA gene silencing could be obtained in vivo on reporter as well as endogenous genes. However, again the liver was the main target limiting this approach to hepatic diseases. It was concluded that 'better delivery methodsy are clearly required before siRNA can be used in therapy, especially to suppress gene expression in tissues other than the liver'. 7 This remains a critical issue for the development of siRNA as an effective therapeutic. More recently, fluorescently labelled siRNA were injected i.v. or i.p. in mice being complexed with cationic lipid liposomes. 16 Their uptake in different tissues was assayed by fluorescence on cryosections. They were observed to be localized in the spleen and kidney after i.v. injection and to remain in the peritonea after their i.p. delivery. Rather high amounts (100 mg) were injected in this localization experiment. Clearly, the need for a delivery method suitable for targeting a broad range of tissues remains required. The demonstration in 1998 of drug and plasmid electrotransfer and gene expression in tumours 18, 19 led to the proposal that in vivo electropulsation was a promising tool for exogenous agents delivery. 20 Furthermore, it was observed that a very efficient in vivo electroloading of large molecules other than plasmids was obtained for proteins, 19 dextran, 21 and antisense oligonucleotides. 22 Electrically mediated gene transfer had been shown to be effective on many tissues: liver, 23 skin, 24 muscle 21, 25 and heart. 26 Delivery is targeted to the volume where the field pulse is applied, that is, under the control of the electrode localization. This technology allows delivery to almost all tissues, after a small surgery when needed. Impressive results were described in the case of muscles where treatment with noninvasive contact electrodes brought a long-lasting expression of therapeutical genes. 27 Recent developments in optical imaging provide continuous monitoring of gene delivery and expression in living animals. 28 As imaging methods are noninvasive, they allow for long-term studies on a single animal. Indeed, reporter gene activity of the same animal as a function of time with no adverse effects either on the reporter gene product or on the animal itself can be accurately followed. This increases the statistical relevance of a study, while decreasing the number of animals required. This is a major advantage over methods where the activity is obtained on tissue extracts or on slices after killing the animal. Exogenous gene expression of fluorescent reporter proteins such as green fluorescent protein (GFP) can be detected by the associated emission using a highly sensitive CCD camera.
In this study, we investigated the effectiveness of electropulsation for the localized delivery of siRNA in adult mice using the thigh muscle as a model system. The resulting inhibitory effect was monitored in living animals over several weeks by whole-body imaging of the GFP protein.
Results

Electrically mediated siRNA delivery
We firstly coelectrotransferred an expression plasmid encoding GFP together with the egfp22 siRNA directed against the GFP mRNA. 29 Nucleic acids in PBS were injected slowly into the mouse thigh muscle under isoflurane anaesthesia. Around 30 s after injection, an electric pulsation was applied. Plate parallel electrodes were maintained in direct electric contact with the shaved skin by a conducting paste. The muscle was electropulsed with square waved pulses. Voltage (120 V), pulse duration (20 ms), number of pulses (8 Â ) and frequency of pulses (1 Hz) were all preset on the Electropulsator. These conditions were chosen since they are known to induce in vivo a high level of reporter gene expression with no tissue damage. 30 As reported previously, a muscle contraction was observed when the electric field was applied. Neither local burns nor oedema nor short-or long-lived loss of limb functions were observed.
Gene silencing in young adult mice When 9-week-old female CL57bl/C mice were electrotreated after injection of the plasmid alone, GFP expression was detected 24 h after electropulsation. GFP fluorescence emission was quantified by digital imaging. Fluorescence was present only in the muscle that was electropulsed. It remained detectable during a long period (more than 23 days) peaking at day 11 ( Figure 1a, b, g ). When the specific siRNA was cointroduced with the plasmid, GFP expression was not detected during the first 11 days but was observed at a low but significant level at day 23 ( Figure 1c, d, g ). Silencing was statistically significant all along those 23 days (P-value o0.05). If an unrelated nonsilencing siRNA (P76 siRNA) was cointroduced with the plasmid, no statistically significant expression changes relative to control could be detected all along the 23 days (Figure 1e , f, g).
Gene silencing in older mice
Electrically mediated gene transfer and siRNA mediated gene silencing could also be obtained in old animals. The GFP expression was detected 24 h after electropulsation following injection of the plasmid alone in 8-month-old balb/c female mice. It remained present during 2 weeks with a peak in fluorescence emission at day 5, a significantly shorter duration of expression when compared with younger animals (Figure 2a, b, g ). When the GFP coding plasmid was cointroduced with the GFP specific siRNA, no expression was observed during this 2 weeks interval (Figure 2c, d, g ). These results were statistically significant up to day 5 (Po0.05). This indicates that gene silencing in muscle was not altered by animal age or strain and that the stability of the siRNA was as good as with younger animals. When an unrelated siRNA was cointroduced with the plasmid, no statistically significant inhibition of GFP expression was detected (Figure 2e , f, g). In vivo electrically mediated siRNA delivery M Golzio et al
Gene silencing in GFP expressing mice
The silencing effect of siRNA was then assayed on the muscle of young C57bl/c mice already expressing the GFP transgene. The GFP coding plasmid was first electrotransferred in the muscle. This gave a long-lasting expression in the control animals as described above. At 48 h after this first electrotransfer, the specific egfp22 siRNA was electroloaded using the same electrical parameters. The same amount of siRNA as in the cotransfer experiments was used. These electrical conditions (long-lasting pulses) were selected taking into account the size of siRNA and our previous in vitro studies on macromolecule electroloading 31 and on in vivo protein electroloading in tumours. 19 Whole-body imaging on the same animal allowed to use the expression on day 2 as an internal control to quantify the relative knockdown of the expression. GFP expression was maintained but at a reduced level when compared to the controls (Figure 3 ). The observed silencing was lower than with the cotransfection approach. However, this 20-30% knockdown was not observed when the specific siRNA was injected on day 2 but without electropulsation ( Figure 3 ). This indicated that electrical treatment was clearly needed for an efficient siRNAs in vivo entry in muscle cells. The siRNA inhibiting effect was detectable from day 5 up to day 9 after its electroloading. The effect was statistically significant on day 5 (Po0.05). This effect was not detectable after 21 days when the GFP expression was vanishing. This last observation was in line with the results obtained with the cointroduction of plasmids and siRNAs (Figure 1a, b) .
Discussion
In this study, we showed that naked synthetic siRNAs could be successfully delivered to the mice muscle by electrotransfer under conditions, where no tissue damages were present 30 and bring the specific inhibition of a cotransferred transgene. Whole-body imaging on live animals allowed us to show that silencing of expression lasted at least 11 days in this tissue whatever the age of the animal. This was longer than what was reported in previous experiments in the liver, where silencing was severely compromised 4 days after the hydrodynamics loading. 12 The stability of the electroloaded siRNA as shown by the duration of the silencing effect reinforces the potential of these molecules as new therapeutic tools. Electrical delivery and associated gene silencing were effective on old animals (9 months, Figure 2 ), while the observations with the hydrodynamics methods were restricted to younger animals (less than 8-10 weeks). This suggests that RNA interference may not be . At 48 h after this first electrotreatment (Day 2), 2 mg of egfp 22 siRNA in 20 ml PBS was electrotransferred (m) while the control muscles (') were electropulsed after the injection of the same volume of buffer. In another control the unrelated P76 siRNA was electrotransferred (J). The last control was to inject the egfp 22 siRNA without the electrical treatment (&). Standard electrical conditions (see Materials and methods) were used for the two successive electrical treatments. Mean fluorescence emission from each muscle was normalized using its emission on day 2 (ie before the second treatment) as an internal control. Four muscles were treated under each condition.
In vivo electrically mediated siRNA delivery M Golzio et al significantly affected by ageing. This clearly is an advantage when considering the potential clinical developments of this method. Plasmid electrotransfer and expression in muscles are known to be very efficient. A recent study reported that 70-80% of the fibres can be transfected after injection of 25 mg of a GFP coding plasmid and by using electrical conditions rather similar to the ones of our study. 32 Emission of the green protein was high even 7 days after the electrical treatment. Our fluorescence analyses also led us to conclude that inhibition of gene expression, and therefore, siRNA delivery, must occur in almost all fibres. This is further supported by our previous report on in vivo electrodelivery in tumours. 19 We observed that delivery into cells was dependent on the size of the molecules. The small propidium iodide was detected in all pulsed cells, b galactosidase, a 400 kDa protein was transferred in only 20% of them while expression of the plasmid was detected in only 5% of the population. SiRNA being a small sized oligoribonucleotide should be delivered in almost all cells upon electrotransfer.
In the gene electrodelivery study in muscle, 32 the histological data showed that there was only limited short-term damage to the fibres. This conclusion was further supported by the lack of inflammation as a result of the electrical treatment. This was confirmed by another study on 7-week-old CL57 mice. 33 However, the same group observed that 20-week-old mice were significantly affected by the electrical treatment. Our results on old mice suggest that this should not affect the gene silencing but shorten the lifetime of the expression.
The weaker inhibition of GFP expression when siRNA was electrotransferred 48 h after the plasmid might result from a suboptimal intracellular concentration of siRNA, as previously observed in the high pressure tail vein injection method. 12 It was indeed observed that the level of inhibition was controlled by the amount of injected siRNA. 12 The dose of siRNA which we used was only 2 mg while much larger amounts (40-50 mg) were used in the high-pressure delivery experiments. 10, 12 The in vivo delivery of siRNA remains problematic if high RNAse activities are present in the target tissue. Several technical reports and hypothesis suggest that siRNA may be the targets of ribonucleases. 34, 35 One problem may be an increase in the level of ribonuclease in electropulsed muscles. One way to circumvent this problem could be to use protective compounds and/or to increase the concentrations of siRNAs used for the in vivo transfection experiments. Indeed, siRNAs bear no chemical modifications and show no apparent toxicity even at high concentrations in cultured cells. 36 Although using high concentrations of siRNA for the electrodelivery experiments may increase knockdown efficiency in vivo, excessive intracellular accumulation of siRNA molecules may have other deleterious nonspecific effects such as the induction of some components of the interferon system 37, 38 or increased inhibition levels of genes with sequences related to the target mRNA ('off-target effects' 39 ). Better knowledge of the structural factors controlling siRNA activity should contribute to minimize the effective dose of siRNA required for efficient knockdown in vivo. 40 Very recently, the localized electrodelivery of plasmid DNA coding for siRNA precursors was described in the rodent retina. 41 While promising, the expression from DNA vectors also faces several problems such as the induction of interferon responses. 42 Otherwise, the uncontrolled sustained expression of inhibitory molecules may be inappropriate for treating certain diseases. 7 These problems should be strongly minimized with the electrodelivery of chemically synthesized siRNA as described in the present work.
In 2002, a pioneering work of McCaffrey et al 10 reported the in vivo delivery of siRNA in mice liver using the hydrodynamic transfection technique and the successful inhibition of a cotransferred luciferase reporter gene. Two independent groups recently extended the therapeutic effectiveness of this siRNA delivery approach on mice models for liver diseases. 9, 13 Our data suggest that electrically mediated transfection may represent a methodology well suited for in vivo localized delivery of siRNAs. Electrical delivery of other nucleic acids and small molecules was obtained not only in muscles but also in other organs. It should therefore open the way for the use of siRNA in therapy 43 being a safe approach for the patient as shown by the clinical developments of electrochemotherapy. 18 We carried out all mice experiments according to the guidelines established by the 'Comité d'éthique' of the CNRS.
Materials and methods
Nucleic acids
The pEGFP C1 plasmid (Clontech, Palo Alto, CA, USA) expresses a mammalian-enhanced version of the GFP. It was prepared from Escherichia coli with a maxiprep endotoxin free cartridge (Qiagen, Hilden, Germany).
The egfp22 siRNA (sense: 5 0 r(GCA AGC UGA CCC UGA AGU UCA U), antisense: 5 0 r(GAA CUU CAG GGU CAG CUU GCC G)) is directed against GFP mRNA. It was designed according to Caplen et al.
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The P76 siRNA (sense: 5 0 r(GCG GAG UGG CCU GCA GGU A)dTT, antisense: 5 0 r(UAC CUG CAG GCC ACU CCG C)dTT) is directed against an unrelated human P76 mRNA and shows no significant homology to mouse transcripts. It was used as a control for specificity of the siRNA construct.
The specific GFP annealed double-stranded siRNA (egfp22) as well as the nonsilencing molecule (P76) were obtained from Qiagen Xeragon (Germantown, MD, USA).
In vivo electropulsation
In total, 10 mg of EGFP plasmid (0.5 mg/ml) in PBS mixed with 2 mg of siRNA (0.4 mg/ml in annealing buffer) were injected slowly (about 15 s) with a Hamilton syringe through a 26G needle (Hamilton, Bonaduz, Switzerland) into tibialis cranialis in mice (Iffa Credo, France) under isoflurane anaesthesia. In the control conditions, 5 ml of water was added to 20 ml of plasmid solution to keep the injection conditions similar. Around 30 s after injection, an electric pulsation was applied. Plate parallel electrodes (length 1 cm, width 0.6 mm) (IGEA, Carpi, Italy) were fitted around the leg. The leg was previously shaved with a cream (Veet). A good electric contact was obtained between the skin and the electrodes by a conducting paste (Eko-gel, Egna, Italy). The muscle was electropulsed with selected parameters using the PS 10
In vivo electrically mediated siRNA delivery M Golzio et al CNRS Electropulsator (Jouan, St Herblain, France). Square waved pulses were delivered as previously described. 30 Voltage (120 V), pulse duration (20 ms) and frequency of pulses (1 Hz) were all preset on the Electropulsator. A train of eight pulses was delivered. All parameters were monitored on-line with an oscilloscope (Metrix, Annecy, France). An electronic switch cutting the pulse as soon as its intensity was 5 A obtained safety against current surge.
Whole-body imaging
High magnification images were obtained under an epifluorescence stereomicroscope by using a cooled CCD camera. 44 The electrically mediated GFP gene transfer in the mouse muscle was detected directly on the anaesthetized animal by digitized stereomicroscopy. Fluorescent muscle fibres were observed through the skin (Figures 1 and 2 ). This procedure allows the observation of expression on the same animal during several weeks.
A stereo fluorescence microscope (Leica MZFL III, Germany) was used for visualization using the Â 0.8 magnification. The whole muscle was observed as a 12 bits 1.3 M pixels image with a cooled CCD Camera (Roper Coolsnap fx). The Meta Vue software (Universal, USA) drives the camera from a Dell computer. The exposure time is set at 1 s with no binning. The fluorescence excitation was obtained with a Mercury Arc lamp (HBO, Osram, Germany) and either the GFP or the G filters (Leica). The GFP fluorescence from the muscle was quantitatively evaluated at different days and thereafter with weekly intervals until the GFP fluorescence was no longer detectable. A transmission picture, a picture with GFP filter and a picture with G (red) filter, was taken on each leg. From the transmission picture, the tibialis cranialis muscle was located and gated to give the region of interest (ROI). On the picture taken with the GFP filter, the mean fluorescence in the gated area (whole muscle) was quantitatively estimated (measure/region measurement). The picture taken with the G filter depicted the autofluorescence from the skin and hair follicles. In our experiments the background fluorescence was sufficiently low not to interfere with our quantification, when GFP emission was present.
To quantify the relative knockdown effect induced by the postintroduction of siRNA (Figure 3) , the respective intensity of each muscle on day 2 was used as an animal specific internal control. Relative fluorescences on day x are the mean of the ratio of the fluorescence on day x to this 'internal control'. This allows to strongly limit the effect of the spreading of the gene expression between the different animals.
Statistical analysis
Four different legs were treated for each condition. Differences between mean fluorescence levels measured in our experiments were statistically evaluated by using an unpaired Student t-test using the prism software (version 4.02, Graphpad).
Note
During submission of this manuscript gene silencing of a luciferase reporter gene and endogenous genes in C57 mice muscles after siRNA electrotransfer was demonstrated by an independent research team. 45 
